Royalty Report: Scientific & Technical Instruments, Therapeutic, Drugs – Collection: 250337

License Grant

The Board, through the University, hereby grants to Licensee a royalty-bearing, exclusive license under Licensed Subject Matter to manufacture, have manufactured, use, import, offer to sell and/or sell Licensed Products within Licensed Territory for use within licensed field.  The Board owns certain Patent Rights and Technology Rights related to Licensed Subject Matter.

All consideration as provided herein, and is further subject to the following rights:
(a) Publish the general scientific findings from research related to Licensed Subject Matter, subject to the terms of Article XI–Confidential Information and Publication; and (b) Use Licensed Subject Matter for research, teaching, patient care, and other academically-related purposes.

License Property

Licensed Products means any product or service sold by Licensee or its affiliates or their sublicensees comprising Licensed Subject Matter pursuant to this agreement.

Patent Rights means Boards rights in the information or discoveries described in invention disclosures, or claimed in any patents and/or patent applications, whether domestic or foreign, as identified hereto.

Patent applications/patent numbers:  PCT/US2011/021692 – Apparatuses and Systems for Generating High-Frequency Shockwave, and Methods of Use
Provisional 61/508,343 US – High Frequency Ultrasound Shockwave Therapy for Cellular Particle Agglomerates

Licensed Subject Matter means inventions and discoveries covered by Patent Rights or Technology Rights within licensed field.

Field of Use

Licensed Field means all fields of use.

RAP device uses rapid pulses of designed acoustic shockwaves to dramatically accelerate the removal of tattoos when used in conjunction with existing lasers. Our technology allows a doctor to treat a patient multiple times in a single office visit and significantly reduce the overall time it takes to remove a tattoo.

License Grant

The University hereby grants to Licensee under the terms and conditions herein specified, an exclusive license to make, have made, use and sell Licensed Products, with the right to sublicense throughout the world, on terms at least as restrictive as those provided herein.

License Property

Subject Technology, shall mean the invention entitled, '_______ Solid-State __________ laser at 193nm' to be built as described in Agreement and unpublished know how directly related to said inventions and to Patent Rights, as herein defined, and all alterations or improvements to the invention.

Licensed Product shall mean any product, process or use thereof (a) which utilizes the Subject Technology; (b) which is covered by an unexpired claim contained in the Patent Rights in the country in which the Licensed Product(s) is made, used, sold or transferred; (c) which is manufactured by using a process which is covered in an unexpired claim contained in the Patent Rights in the country in which the Licensed Product(s) is made, used, sold or transferred; or (d) the use of which is covered in an unexpired claim contained in the Patent Rights in the country in which the Licensed Product(s) are made, used, sold, or transferred.

Summary of Laser System: The laser system will be developed by Martin Richardson's Laser Development Group in the LPL at CREOL. The laser system is expected to generate Q-switched laser pulses at _______nm with energies of ______ mJ, with a ___________ ns pulse. duration at a repetition rate of ____ Hz. The laser system will most probably use ________ as a laser medium. The final system will incorporate a ___________ and _________________ system, allowing conversion to 193nm with an expected overall conversion of ________ to the UV.

Field of Use

Field of Use shall mean ________ lasing at a wavelength of 193 nm, and the range of associated with the _______ system incorporating _______ and frequency conversion to the UV of this laser.

License Grant

The Licensors grant an exclusive license under Licensed Subject Matter to discover, research, develop, make, have made, use, offer for sale, sell and import licensed products and identified products within Licensed Territory for use within Licensed Field to:
– Publish the general scientific findings from research related to Licensed Subject Matter and Licensed Products subject to the confidentiality terms, and
– Use Licensed Subject Matter or Identified Products solely for research, teaching and other educationally-related, non-commercial purposes only.

License Property

The patents are for Transgenic Animal Models for Cardiac hypertrophy and Methods and Use Thereof, Transgenic Animal Models for Cardiac hypertrophy and Methods and Use Thereof,  Transgenic Animal Models for Cardiac hypertrophy and Methods and Use Thereof and Methods and Compositions for Therapeutic Intervention in Cardiac Hypertrophy.

Licensed Product means any compound, assay, method, reagent, technology, or product comprising Licensed Subject Matter pursuant to this Agreement.

Licensed Subject Matter means inventions and discoveries claimed in Patent Rights or covered by Technology Rights within Licensed Field.

Technology Rights means Licensors rights in technical information, know-how, processes, procedures, compositions, devices, methods, formulas, protocols, techniques, software, designs, drawings or data created by Inventors relating to Licensed Subject Matter which are not covered by Patent Rights, but useful.

Field of Use

Licensed Field means the discovery, development, manufacture, use, sale, offer for sale, and import of pharmaceutical, biologic, gene therapy and/or health care products for the treatment, prevention and/or diagnosis of cardiac hypertrophy and heart failure by inhibition of calcineurin activity and calmodulin-dependent protein activity, and NFAT activity; the development, manufacture and use of assays for the identification of pharmaceutical and/or biologic agents for the treatment, prevention, and/or diagnosis of cardiac hypertrophy and heart failure by inhibition of calcineurin activity and calmodulin-dependent protein activity, and NFAT activity; and the development, manufacture and use of assays useful in the diagnosis of, prognosis of, or determination of predisposition to, cardiac hypertrophy and heart failure by inhibition of calcineurin activity and calmodulin-dependent protein activity, and NFAT activity.